1. Home
  2. XOMA vs HPP Comparison

XOMA vs HPP Comparison

Compare XOMA & HPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XOMA
  • HPP
  • Stock Information
  • Founded
  • XOMA 1981
  • HPP 2009
  • Country
  • XOMA United States
  • HPP United States
  • Employees
  • XOMA N/A
  • HPP N/A
  • Industry
  • XOMA Biotechnology: Pharmaceutical Preparations
  • HPP Real Estate
  • Sector
  • XOMA Health Care
  • HPP Finance
  • Exchange
  • XOMA Nasdaq
  • HPP Nasdaq
  • Market Cap
  • XOMA 355.6M
  • HPP 420.6M
  • IPO Year
  • XOMA N/A
  • HPP 2010
  • Fundamental
  • Price
  • XOMA $26.76
  • HPP $3.14
  • Analyst Decision
  • XOMA Strong Buy
  • HPP Hold
  • Analyst Count
  • XOMA 2
  • HPP 11
  • Target Price
  • XOMA $81.50
  • HPP $4.75
  • AVG Volume (30 Days)
  • XOMA 36.4K
  • HPP 6.1M
  • Earning Date
  • XOMA 03-07-2025
  • HPP 02-20-2025
  • Dividend Yield
  • XOMA N/A
  • HPP 3.19%
  • EPS Growth
  • XOMA N/A
  • HPP N/A
  • EPS
  • XOMA N/A
  • HPP N/A
  • Revenue
  • XOMA $21,606,000.00
  • HPP $847,713,000.00
  • Revenue This Year
  • XOMA $511.48
  • HPP N/A
  • Revenue Next Year
  • XOMA $26.91
  • HPP N/A
  • P/E Ratio
  • XOMA N/A
  • HPP N/A
  • Revenue Growth
  • XOMA 389.82
  • HPP N/A
  • 52 Week Low
  • XOMA $18.57
  • HPP $2.39
  • 52 Week High
  • XOMA $35.00
  • HPP $9.25
  • Technical
  • Relative Strength Index (RSI)
  • XOMA 47.49
  • HPP 53.31
  • Support Level
  • XOMA $23.88
  • HPP $2.84
  • Resistance Level
  • XOMA $29.02
  • HPP $3.04
  • Average True Range (ATR)
  • XOMA 1.27
  • HPP 0.17
  • MACD
  • XOMA 0.27
  • HPP 0.06
  • Stochastic Oscillator
  • XOMA 56.03
  • HPP 94.75

About XOMA XOMA Corporation

XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. When XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes.

About HPP Hudson Pacific Properties Inc.

Hudson Pacific Properties Inc is a real estate investment trust that acquires, operates, and owns office buildings and media and entertainment properties, such as sound stages, on America's West Coast. The company focuses on developed, urban markets in Northern California, Southern California, and the Pacific Northwest. In terms of total square footage, the vast majority of Hudson Pacific's real estate portfolio is composed of office properties located in the Greater Seattle, San Francisco, and Los Angeles areas. The company operates in two reportable segments; office properties & related operations; and studio properties & related operations. The majority of revenue is derived from the office properties & related operations segment.

Share on Social Networks: